+ |
LYN | up-regulates activity
phosphorylation
|
FCGR2B |
0.44 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-249380 |
Tyr292 |
GAENTITySLLMHPD |
in vitro |
|
pmid |
sentence |
8756631 |
Therefore, we conclude that FcgammaRIIb1 phosphorylation upon BCR-FcgammaR coligation is most likely due to BCR-associated Lyn |
|
Publications: |
1 |
Organism: |
In Vitro |
+ |
MARCHF9 | down-regulates quantity by destabilization
ubiquitination
|
FCGR2B |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-271541 |
|
|
Homo sapiens |
B-lymphocyte Cell Line |
pmid |
sentence |
19457934 |
MARCH9, a member of the RING-CH family of transmembrane E3 ubiquitin ligases, down-regulates CD4, major histocompatibility complex-I (MHC), and ICAM-1 in lymphoid cells. To identify novel MARCH9 substrates, we used high throughput flow cytometry and quantitative mass spectrometry by stable isotope labeling by amino acids in cell culture (SILAC) to determine the differential expression of plasma membrane proteins in a MARCH9-expressing B cell line. This combined approach identified 13 potential new MARCH9 targets. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
Immune complexes | up-regulates activity
|
FCGR2B |
0.7 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-249522 |
|
|
Homo sapiens |
Macrophage |
pmid |
sentence |
25475856 |
Low affinity-activating Fcgamma receptors (FcgammaRs) that bind immune complexes are controlled by a single inhibitory receptor, FcgammaRIIb (CD32b). |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
FCGR2B | down-regulates activity
|
TLR4 |
0.391 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-249525 |
|
|
Homo sapiens |
|
pmid |
sentence |
24445665 |
Triggering of FcgammaRIIB also subverted the normal activation of DCs by the TLR4 agonist lipopolysaccharide. In addition, triggering of FcgammaRIIB by immune complexes might affect the differentiation of moDCs. When moDCs develop from monocytes invitro in the presence of immune complexes, their differentiation is hampered and they no longer produce IL-12 in response to TLR4 agonists. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |